Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SSX2 antibody (C-Term)

The Rabbit Polyclonal anti-SSX2 antibody has been validated for WB. It is suitable to detect SSX2 in samples from Human.
Catalog No. ABIN927674

Quick Overview for SSX2 antibody (C-Term) (ABIN927674)

Target

See all SSX2 Antibodies
SSX2 (Synovial Sarcoma, X Breakpoint 2 (SSX2))

Reactivity

  • 47
  • 3
  • 2
Human

Host

  • 41
  • 6
Rabbit

Clonality

  • 44
  • 3
Polyclonal

Conjugate

  • 19
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This SSX2 antibody is un-conjugated

Application

  • 32
  • 13
  • 13
  • 9
  • 5
  • 5
  • 5
  • 4
  • 3
  • 1
  • 1
Western Blotting (WB)
  • Binding Specificity

    • 15
    • 7
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    C-Term

    Purification

    Purified

    Immunogen

    SSX2 antibody was raised in rabbit using the C terminal of SSX2 as the immunogen
  • Application Notes

    WB: 0.2-1 µg/mL
    Optimal conditions should be determined by the investigator.

    Comment

    SSX2 Blocking Peptide, (ABIN939235), is also available for use as a blocking control in assays to test for specificity of this SSX2 antibody

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Concentration

    Lot specific

    Buffer

    Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

    Handling Advice

    Avoid repeated freeze/thaw cycles.

    Storage

    4 °C/-20 °C

    Storage Comment

    Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
  • Target

    SSX2 (Synovial Sarcoma, X Breakpoint 2 (SSX2))

    Alternative Name

    SSX2

    Background

    SSX2 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. The encoded hybrid proteins are probably responsible for transforming activity. Two transcript variants encoding distinct isoforms have been identified for this gene. Synonyms: Polyclonal SSX2 antibody, Anti-SSX2 antibody, synovial sarcoma, X breakpoint 2 antibody, HD21 antibody, HOM-MEL-40 antibody, MGC119055 antibody, MGC15364 antibody, MGC3884 antibody, SSX antibody.
You are here:
Chat with us!